Athersys, Inc. (ATHXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST
Athersys Market Cap
Athersys has a market cap or net worth of $62 as of February 6, 2026. Its market cap has decreased by -99.98% in one year.
Market Cap
62.00
Enterprise Value
n/a
Revenue
80.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 12, 2007, Athersys's market cap has decreased from 34.78M to 62.00, a decrease of -100.00%. That is a compound annual growth rate of -50.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 62.00 | - |
| Dec 31, 2025 | 62.00 | - |
| Dec 31, 2024 | 62.00 | -99.99% |
| Dec 29, 2023 | 1.23M | -91.28% |
| Dec 30, 2022 | 14.16M | -93.33% |
| Dec 31, 2021 | 212.32M | -38.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| American Oriental Bioengineering | 88.00 |
| RenovaCare | 87.00 |
| Cardax | 83.00 |
| Bioasis Technologies | 79.00 |
| Gelesis Holdings | 73.00 |
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |